Nature Biotechnology, Published online: 13 October 2026; doi:10.1038/s41587-026-03310-1 Chimeric antigen receptor natural killer cells to treat autoimmune disease and cancer are generated in vivo.
ORIGINAL PAPER
In vivo engineering of CAR natural killer cells for immunotherapy using ligand-directed lipid nanoparticles
WHAT WE KNOW
Nature Biotechnology, Published online: 13 October 2026; doi:10.1038/s41587-026-03310-1 Chimeric antigen receptor natural killer cells to treat autoimmune disease and cancer are generated in vivo.
WATCH NEXT
Review the primary source, validate the main result, and establish whether any listed-company transmission is direct.
EVIDENCE
What the evidence supports so far
Research signals
Classification pending.
What remains unverified
The full methodology, effect size, and limitations still require analyst review.
Company impact remains unverified until a direct economic transmission is established.